Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

East Hanover, New Jersey 07936


Purpose:

Gastroesophageal Reflux Disease (GERD) is a common disorder caused by the reflux of gastric (stomach) acid into the esophagus. The exposure of the lining of the esophagus to the acid will cause damage to the esophagus over time. The symptoms of GERD include heartburn and acid regurgitation This study will determine if Tegaserod alone and in combination with omeprazole is safe and relieves the symptoms of heartburn.


Criteria:

Inclusion Criteria: - History of physician diagnosed GERD - Heartburn and Regurgitation 3 Days during the week prior to screening Exclusion Criteria: - History of erosive esophagitis, Barrett's esophagus, esophageal stricture, scleroderma, Zollinger-Ellison Syndrome, known primary disorder - History or presence of infection or inflammation of the small or large intestine, gastrointestinal malignancy, history of upper GI surgery - Use of PPI during the last four weeks prior to screening Other protocol-defined inclusion/exclusion criteria may apply.


NCT ID:

NCT00149851


Primary Contact:

Study Chair
Novartis
East Hanover NJ


Backup Contact:

N/A


Location Contact:

East Hanover, New Jersey 07936
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.